Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 26,465 | 15,404 | 13,187 | 11,312 | 16,335 |
| Cost of Goods | 9,949 | 8,005 | 8,109 | 8,229 | 9,871 |
| Gross Profit | 16,517 | 7,399 | 5,078 | 3,083 | 6,465 |
| Operating Expenses | 11,077 | 6,809 | 8,462 | 10,723 | 8,319 |
| Operating Income | 6,388 | 595 | -3,275 | -7,411 | -983 |
| Other Income | 389 | 144 | 240 | 662 | 1,173 |
| Pre-tax Income | 6,777 | 739 | -3,035 | -6,749 | 190 |
| Income Tax | -4,413 | -88 | 5 | 9 | 16 |
| Net Income Continuous | 11,190 | 827 | -3,040 | -6,758 | 174 |
| Net Income | $11,190 | $827 | $-3,040 | $-6,758 | $174 |
| EPS Basic Total Ops | 1.11 | 0.08 | -0.31 | -0.68 | 0.02 |
| EPS Basic Continuous Ops | 1.11 | 0.08 | -0.31 | -0.68 | 0.02 |
| EPS Diluted Total Ops | 0.98 | 0.08 | -0.31 | -0.68 | 0.02 |
| EPS Diluted Continuous Ops | 0.98 | 0.08 | -0.31 | -0.68 | 0.02 |
| EBITDA(a) | $7,097 | $1,601 | $-2,180 | $-6,326 | $-73 |